IRCT2012072210363N1已完成未知
An open trial of Duloxetine in the treatment of children with attention-deficit/hyperactivity disorder
niversity of Social Welfare and Rehabilitation Sciences0 个研究点目标入组 10 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 10
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 6 years 至 12 years（—）
- 性别
- All
入选标准
- •Inclusion criteria : ADHD diagnosis according to DSM-IV-TR that is applied by two psychiatrists; age between 6-12 years old
- •Exclusion criteria : mental retardation; history of heart disease; drug sensitivity; comorbidity of severe mental illnesses such as bipolar disorder, major depressive disorder, conduct disorder, psychosis ; history of seizure.
排除标准
- 未提供
研究者
相似试验
未知
3 期
A Phase III Clinical Trial of Duloxetine in Participants With FibromyalgiaFibromyalgiaJPRN-jRCT2080221737SHIONOGI & CO., LTD.
未知
3 期
A phase 3 clinical trial of duloxetine in patients with osteoarthritisosteoarthritisJPRN-jRCT2080222625Shionogi & Co., Ltd.
未知
3 期
A phase 3 clinical trial of duloxetine in patients with chronic low back paiChronic low back painJPRN-jRCT2080222083SHIONOGI & CO., LTD.
招募中
2 期
The use of duloxetine for the treatment of chemotherapy-induced peripheral neuropathyChemotherapy-induced peripheral neuropathyNeurological - Other neurological disordersCancer - Any cancerACTRN12617000139370Prince of Wales Hospital48
已完成
4 期
An Open Label Trial of Duloxetine in the Treatment of Irritable Bowel Syndrome and Comorbid Generalized Anxiety DisorderIrritable Bowel SyndromeGeneralized Anxiety DisorderNCT00961298West Penn Allegheny Health System17